Introduction

In recent years, both the Tamil Nadu Government and the Central Government of India have increasingly promoted HPV vaccination among adolescent girls and women. Despite this, many people remain unaware of why this vaccine is considered highly important in modern preventive medicine. The HPV vaccine is not merely another routine injection. It is part of a large-scale cancer prevention strategy aimed at reducing the burden of cervical cancer, one of the most common cancers affecting women worldwide.

What is HPV?

Human Papillomavirus is a group of viruses primarily transmitted through intimate skin-to-skin sexual contact. More than 100 HPV variants exist, but only certain high-risk strains are strongly associated with cancer development. Among these, HPV 16 and HPV 18 are considered the major cancer-associated high-risk strains. Persistent infection with these strains significantly increases the risk of cervical cancer. At the same time, some HPV strains such as HPV 6 and HPV 11 are commonly associated with genital warts and are generally considered lower-risk strains. Importantly, most HPV infections do not become cancerous. In many individuals, the immune system clears the infection naturally within a few years. However, in some people, the infection may persist silently for years and gradually induce abnormal cellular changes.

Why Cervical Cancer Is the Main Focus

Although HPV may also contribute to: * penile cancer, * anal cancer, * vaginal cancer, * vulvar cancer, * and certain throat cancers, cervical cancer remains the primary public health focus because the association between HPV and cervical cancer is particularly strong. The cervix is the lower portion of the uterus located at the upper end of the vaginal canal. This region contains a transformation zone that is especially vulnerable to persistent HPV-related cellular changes. One of the major reasons cervical cancer prevention is possible is because the disease often develops slowly over many years. Before cancer develops, precancerous cellular changes may silently persist, creating opportunities for vaccination and screening

Why HPV Vaccination Is Recommended Early

The HPV vaccine works most effectively before exposure to the virus occurs. This is the central scientific principle behind HPV vaccination programs. The vaccine is preventive rather than curative. It helps prevent future HPV infections but does not eliminate an HPV infection already present within the body. For this reason, vaccination is ideally recommended during adolescence, commonly between 9–14 years of age, before significant sexual exposure occurs. Some adults up to the age of 45 years may still benefit depending on individual risk factors and prior exposure history. However, the overall preventive benefit statistically decreases as age and cumulative HPV exposure increase.

Common HPV Vaccines

Several HPV vaccines are currently available globally and in India, including: * Gardasil, * Gardasil 9, * Cervarix, * and Cervavac. These vaccines primarily target high-risk HPV strains associated with cervical cancer, especially HPV 16 and HPV 18.

India has increasingly focused on HPV vaccination as a national cancer prevention strategy. Government initiatives have begun promoting free or subsidized vaccination for adolescent girls through public healthcare systems. One major reason for this public health approach is that preventing cervical cancer through vaccination is substantially safer, simpler, and more economically sustainable than treating advanced cancer later in life. Public health experts consider HPV vaccination one of the most impactful preventive interventions in women’s health

Symptoms of Cervical Cancer

Early Cervical Cancer may not produce noticeable symptoms. As the disease progresses, symptoms may include: * abnormal vaginal bleeding, * bleeding after intercourse, * bleeding between menstrual cycles, * postmenopausal bleeding, * persistent foul-smelling vaginal discharge, * pelvic pain, * and pain during intercourse. Importantly, these symptoms do not automatically indicate cancer, but persistent symptoms should always be medically evaluated

Conclusion

HPV vaccination represents one of the most important cancer prevention initiatives in modern medicine. Although HPV infection is extremely common and often harmless, persistent infection with high-risk strains can gradually increase cervical cancer risk in some women Vaccination before viral exposure, combined with awareness and regular screening, has the potential to significantly reduce cervical cancer burden in future generations.

References

  • 1. World Health Organization. Human papillomavirus (HPV) and cervical cancer. 2024
  • 2. Centers for Disease Control and Prevention. HPV Vaccination Recommendations. 2024
  • 3. Bruni L, Albero G, Serrano B, et al. Human Papillomavirus and Related Diseases Report. ICO/IARC Information Centre on HPV and Cancer. 2023
  • 4.4. Arbyn M, Xu L, Simoens C, Martin-Hirsch PP. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors. Cochrane Database of Systematic Reviews. 2018
  • 5. Basu P, Malvi SG, Joshi S, et al. Vaccine efficacy against persistent human papillomavirus infection among Indian women. International Journal of Cancer. 2021